BMRN
BioMarin Pharmaceutical Inc.
NASDAQ · Healthcare · Biotechnology · US
$66.35
−0.12%Margins
Gross margin
75.5%
EBITDA margin
11.3%
EBIT margin
8.0%
Net margin
2.1%
FCF margin
21.5%
1.2%
Return on equity
0.6%
Return on assets
2.6%
Return on invested capital
0.34x
Asset turnover
$857.1M
Cash from operations
$4.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026